In this issue: 02 G uest editorial The ABCs for lowerextremity acute DVTs 07 C omment & analysis The vascular influencer: Response to February’s editorial on social media
MARCH 2023 Volume 19 Number 03
THE OFFICIAL NEWSPAPER OF THE
10 A VF 2023 VS interviews bioprosthetic valve FIH trial investigator 17 VAM Vascular Annual Meeting registration opens as details of the program are fleshed out www.vascularspecialistonline.com
NEW STUDY DEMONSTRATES IVC FILTERS ‘SAFE AND EFFECTIVE’ IN TREATING VENOUS THROMBOEMBOLISM By Clare Tierney, Jocelyn Hudson, Beth Bales and Urmila Kerslake FEW ADVERSE EVENTS ARE connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into pulmonary embolisms (PEs), according to the findings of the PRESERVE (Predicting the safety and effectiveness of inferior vena cava filters) trial, published jointly in the Journal of Vascular and Interventional Radiology (JVIR) and the Journal of Vascular Surgery Venous and Lymphatic Disorders (JVS-VL). PRESERVE is an FDA-directed
SCVS PREVIEW
See page 4
Four decades of AAAs in the US:
Rare epidemiological study establishes women are diagnosed and repaired 10 years later than men By Bryan Kay
COMMENT &ANALYSIS ABDOMINAL AORTIC ANEURYSM (AAA) DIAGNOSIS and repair occurs among women almost 10 years later than in men—with similar age-adjusted mortality—the 2023 Society for Clinical Vascular Surgery (SCVS) annual meeting in Miami (March 25–29) is set to be told. The finding is part of a rare U.S. popula tion-based study of AAA trends, spanning nearly 40 years, carried out by researchers at the Mayo Clinic in Rochester, Minnesota, underscoring already established evidence showing that incidence of ruptured AAAs and aortic-related mortality have decreased significantly in the population over time. The epidemiological analysis was conducted by first-named author Indrani Sen, MBBS, an assistant professor of surgery in the Mayo Clinic Health System, senior researcher Manju Kalra, MBBS, a professor of surgery in Mayo’s division of vascular and endovascular surgery, and colleagues. They used the Rochester Epidemiology Project—which captures population-based data, not merely hospital-based datasets—to track changes over the four-decade-long study period (1980–2017), a stretch of time that includes the coming of the endovascular revolution at the turn of the century, and the institution in 2007 of AAA screening for men at the age of 65 who have ever smoked. The study included 1,537 patients, 75% of them male and with a median age of 74 years. Diagnosis of AAA was made at pre-
See page 4
FROM THE SVS PRESIDENT: SUPPORTING ONE ANOTHER The Society for Vascular Surgery (SVS) has a vision that is unwavering, writes Michael C. Dalsing, MD. We desire quality vascular care for all patients by providing our members with the information and tools they need to provide best care. We believe the goal is the right care, by the right provider, at the right time, and in the right place for each patient. Over the last few months, there has been much debate amongst members regarding quality and appropriateness of care across various healthcare settings. This has been stimulated by
See page 6
Vascular Specialist 9400 W. Higgins Road, Suite 315 Rosemont, IL 60018
CHANGE SERVICE REQUESTED
Presorted Standard U.S. Postage PAID Permit No. 384 Lebanon Jct. KY